R-MVST Cells for Treatment of Viral Infections in Children and Young Adults — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults — Stella

Recruiting

Back to Epstein-Barr Virus trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Columbia University Medical Center / New-York Presbyterian, New York, New York

Key details

Phase

Early testing

Sponsor

Columbia University

Enrollment target

~18 participants

Started

April 2025

Primary completion

April 2029

Age range

3 Months – 26 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov